Newsroom

Industry News

7 Apr

Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif., April 07, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts...

Read more

6 Apr

Monster Digital Announces New Customer Agreement with ZUMM

SIMI VALLEY, CA–(Marketwired – Apr 6, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ), (“Monster Digital” or “the Company”), which develops, markets and distributes Monster Digital® branded products for use in high-performance consumer electronics, mobile products and computing applications, today announced a new customer relationship with ZUMM...

Read more

5 Apr

Monster Digital, Inc. Announces Gulf Coast Panama Jack as a New Customer

SIMI VALLEY, CA–(Marketwired – Apr 5, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ), (“Monster Digital” or “the Company”), which develops, markets and distributes Monster Digital® branded products for use in high-performance consumer electronics, mobile products and computing applications, today announced Gulf Coast Panama Jack as a...

Read more

5 Apr

Aytu BioScience Presents Latest Clinical Findings for Natesto® at ENDO 2017, the National Endocrine Society’s Annual Scientific Meeting

ENGLEWOOD, Colo., April 4, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented two posters demonstrating the safety advantages of Natesto® testosterone nasal gel, including the one-year hematologic safety and tolerability...

Read more

4 Apr

Onconova Therapeutics Announces Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5 Inhibitor and dual FLT3 and Src inhibitor at 2017 American Association of Cancer Research (AACR) Annual Meeting

NEWTOWN, Pa., April 04, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes, announced promising pre-clinical data for first-in-class dual inhibitor of CDK4/6 + ARK5,...

Read more

3 Apr

MTBC Announces Launch of Accountable Care Organization Analytics Module

SOMERSET, NJ–(Marketwired – Apr 3, 2017) – MTBC ( NASDAQ : MTBC ) ( NASDAQ : MTBCP ), a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, announced the launch of its accountable care organization (ACO) analytics module, the most recent addition to its...

Read more

3 Apr

Cytori Appoints Gregg Lapointe to Board of Directors

SAN DIEGO, April 03, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) (“Cytori” or the “Company”) today announced that Gregg Lapointe has joined the Company’s Board of Directors to serve as an independent director, effective March 31, 2017. Mr. Lapointe has over 20 years of experience in the pharmaceutical and medical...

Read more

Page 20 of 244« First...10...1819202122...304050...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address